Literature DB >> 6388359

Prostaglandin I2 attenuates ischemic acute renal failure in the rat.

M D Lifschitz, J L Barnes.   

Abstract

We gave prostaglandin I2 (PGI2) (8 ng X kg-1 X min-1 i.v.) for 20 min before, during, and 20 min after clamping of the rat left renal artery for 40 min to evaluate the effect of PGI2 in this model of acute renal failure. Control animals were given glycine buffer (PGI2 diluent). Glomerular filtration rate was estimated by the clearance of inulin 24 h later from each kidney. In group I rats (studied during hydropenia) inulin clearance in the control (right) kidney averaged 1.4 ml/min. Inulin clearance in kidneys exposed to 40 min of ischemia was 0.05 (glycine treated) versus 0.22 (PGI2 treated) ml/min. Although PGI2 offered significant protection in the group I animals, the differences were small and many of the glycine-treated ischemic kidneys were anuric. In the group II studies the same protocol was employed except that 5% body wt volume expansion was done with Ringer solution prior to measurement of inulin clearance. In the group II rats inulin clearance in control (right) kidneys averaged 1.5 ml/min. Inulin clearance after 40 min of renal ischemia was 0.04 ml/min in glycine-treated rats versus 0.90 ml/min in PGI2-treated animals. Histological examination of the group II ischemic kidneys revealed cellular necrosis and cast formation in the S3 segments of the glycine-treated animals and significantly less necrosis and cast formation in the PGI2-treated animals. The degree of necrosis and casts was inversely related to inulin clearance. Accordingly, PGI2 significantly attenuated the fall in inulin clearance measured 24 h after ischemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388359     DOI: 10.1152/ajprenal.1984.247.5.F714

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Efficacy of prostaglandin I2 analog on liver grafts subjected to 30 minutes of warm ischemia.

Authors:  A Kishida; Y Kurumi; M Kodama
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study.

Authors:  K Spargias; E Adreanides; G Giamouzis; S Karagiannis; A Gouziouta; A Manginas; V Voudris; G Pavlides; D V Cokkinos
Journal:  Eur J Clin Pharmacol       Date:  2006-07-11       Impact factor: 2.953

3.  Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.

Authors:  C Hatziantoniou; N Papanikolaou
Journal:  Experientia       Date:  1986-06-15

4.  Effects of a stable prostacyclin analog on experimental ischemic acute renal failure.

Authors:  M Tobimatsu; Y Ueda; S Saito; T Tsumagari; K Konomi
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

5.  Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited.

Authors:  J M Klausner; I S Paterson; L Kobzik; C Rodzen; C R Valeri; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

Review 6.  The kallikrein-kinin system in health and in diseases of the kidney.

Authors:  Masao Kakoki; Oliver Smithies
Journal:  Kidney Int       Date:  2009-02-04       Impact factor: 10.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.